Gearing Up for Biosimilars

Publication
Article
BioPharm InternationalBioPharm International-05-15-2017
Volume 2017 eBook
Issue 1
Pages: s22-s26

Contract manufacturers prepare for anticipated biosimilars manufacturing demands through expansion and acquisition.

Compared to traditional small-molecule generics, the R&D costs and development times for biosimilars are significantly greater. With demand for services in the biosimilars space set to soar, many contract development and manufacturing organizations are increasing their capabilities in this field.  Expansions including in-house development, partnerships and joint ventures, or bolt-on acquisitions are summarized.

 

Download BioPharm International's

2017 Outsourcing Resources eBook

.

 

 

 

 

Articles in this issue
Wellspring_225.jpg
Customer Relationship Management in Contract Manufacturing
ColdChain_225.jpg
Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies
TechTransfer_2251495479190893.jpg
Getting Biopharmaceutical Tech Transfer Right the First Time
CMOs_225.jpg
CMOs Tackle New Challenges
Biosimilars_225.jpg
Gearing Up for Biosimilars
InsourcingOutsourcing_225.jpg
Insourcing vs Outsourcing: Choosing the Right Strategy
Operations_225.jpg
Operations and Quality Oversight of CMOs
QualityMetrics_225.jpg
Quality Metrics and CMO Agreement
Audits_225.jpg
Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification
Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
William K. Oh, MD
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Novotech Named Best Australian CRO at Asia-Pacific Biopharma Excellence Awards

Patrick Lavery
March 28th 2025
Article

Winners are selected entirely through industry voting, with those honored representing recognition by their peers.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Curia Expands Sterile Fill/Finish Site in UK

Feliza Mirasol
March 20th 2025
Article

Curia plans to expand its sterile fill/finish capabilities at its Glasgow, UK, site and gives updates on an ongoing expansion at its Albuquerque, NM, site.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Avantor Presents Completed Hydration Expansion at DCAT Week 2025

Susan Haigney
March 18th 2025
Article

The company gave a first look at its completed expansion at its manufacturing site in Gliwice, Poland during DCAT Week 2025 in New York City.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

DCAT Member Companies Present Latest News to Start DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

© 2025 MJH Life Sciences

All rights reserved.